A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma.

Villanueva, Gabriela; Guscott, Martin; Schaiquevich, Paula; Sampor, Claudia; Combs, Ryan; Tentoni, Nicolás; Hwang, Miriam; Lowe, Jennifer; Howard, Scott

Villanueva, Gabriela; Guscott, Martin; Schaiquevich, Paula; Sampor, Claudia; Combs, Ryan; Tentoni, Nicolás; Hwang, Miriam; Lowe, Jennifer; Howard, Scott.

Afiliação

Villanueva G; Resonance, Inc., 5239 Jeffrey Keith Drive, Arlington, TN 38002, USA.
Guscott M; Resonance, Inc., 5239 Jeffrey Keith Drive, Arlington, TN 38002, USA.
Schaiquevich P; Resonance, Inc., 5239 Jeffrey Keith Drive, Arlington, TN 38002, USA.
Sampor C; Resonance, Inc., 5239 Jeffrey Keith Drive, Arlington, TN 38002, USA.
Combs R; Resonance, Inc., 5239 Jeffrey Keith Drive, Arlington, TN 38002, USA.
Tentoni N; Resonance, Inc., 5239 Jeffrey Keith Drive, Arlington, TN 38002, USA.
Hwang M; Laboratory of Applied Statistics in the Health Sciences, Faculty of Medicine, University of Buenos Aires, Paraguay 2155, Buenos Aires C1121 ABG, Argentina.
Lowe J; Resonance, Inc., 5239 Jeffrey Keith Drive, Arlington, TN 38002, USA.
Howard S; Resonance, Inc., 5239 Jeffrey Keith Drive, Arlington, TN 38002, USA.

Cancers (Basel) ; 15(5)2023 Feb 25.

Article em En | MEDLINE | ID: mdl-36900250

Palavras-chave

high-dose methotrexate; overall response rate; primary central nervous system lymphoma; progression-free survival; rituximab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google